Concepts (165)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Resuscitation | 2 | 2021 | 223 | 1.320 |
Why?
|
| Delivery, Obstetric | 3 | 2023 | 227 | 1.260 |
Why?
|
| Simulation Training | 2 | 2020 | 149 | 1.190 |
Why?
|
| Interdisciplinary Communication | 2 | 2018 | 280 | 1.090 |
Why?
|
| Receptors, IgG | 4 | 2019 | 102 | 1.050 |
Why?
|
| Neonatology | 3 | 2019 | 42 | 0.970 |
Why?
|
| Apnea | 1 | 2021 | 30 | 0.820 |
Why?
|
| Cyanosis | 1 | 2021 | 40 | 0.810 |
Why?
|
| Patient Care Team | 4 | 2021 | 795 | 0.780 |
Why?
|
| Pregnancy, High-Risk | 2 | 2018 | 49 | 0.770 |
Why?
|
| Obstetric Labor Complications | 2 | 2018 | 95 | 0.750 |
Why?
|
| Workload | 1 | 2021 | 198 | 0.730 |
Why?
|
| Computers, Handheld | 1 | 2020 | 69 | 0.720 |
Why?
|
| Intensive Care Units, Neonatal | 2 | 2018 | 273 | 0.690 |
Why?
|
| Fetal Viability | 1 | 2019 | 29 | 0.680 |
Why?
|
| Neonatologists | 1 | 2019 | 16 | 0.680 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2020 | 252 | 0.590 |
Why?
|
| Patient Handoff | 1 | 2017 | 39 | 0.590 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2014 | 265 | 0.560 |
Why?
|
| Prenatal Care | 1 | 2019 | 325 | 0.560 |
Why?
|
| Counseling | 1 | 2019 | 381 | 0.550 |
Why?
|
| C-Reactive Protein | 3 | 2015 | 527 | 0.510 |
Why?
|
| Infant, Newborn | 10 | 2021 | 8223 | 0.500 |
Why?
|
| Carotid Artery Injuries | 1 | 2011 | 40 | 0.400 |
Why?
|
| Endothelial Cells | 3 | 2019 | 1048 | 0.370 |
Why?
|
| Hypertension | 2 | 2019 | 1503 | 0.350 |
Why?
|
| Pregnancy | 10 | 2023 | 7573 | 0.330 |
Why?
|
| src-Family Kinases | 1 | 2011 | 478 | 0.330 |
Why?
|
| Obstetrics and Gynecology Department, Hospital | 2 | 2018 | 14 | 0.320 |
Why?
|
| Obesity | 2 | 2019 | 2884 | 0.280 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2003 | 639 | 0.240 |
Why?
|
| Patient Simulation | 1 | 2023 | 40 | 0.220 |
Why?
|
| Twins, Conjoined | 1 | 2023 | 28 | 0.220 |
Why?
|
| Ventricular Function | 1 | 2003 | 93 | 0.210 |
Why?
|
| Angiotensin II | 1 | 2003 | 198 | 0.210 |
Why?
|
| Apgar Score | 1 | 2021 | 55 | 0.200 |
Why?
|
| Umbilical Arteries | 1 | 2021 | 59 | 0.200 |
Why?
|
| Heart Rate, Fetal | 1 | 2021 | 51 | 0.200 |
Why?
|
| Labor, Obstetric | 1 | 2021 | 86 | 0.200 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2003 | 630 | 0.190 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 2019 | 34 | 0.180 |
Why?
|
| Hexosamines | 1 | 2019 | 25 | 0.180 |
Why?
|
| Heart | 2 | 2003 | 1223 | 0.180 |
Why?
|
| Gestational Age | 2 | 2019 | 1069 | 0.170 |
Why?
|
| Lymphatic Abnormalities | 1 | 2019 | 29 | 0.170 |
Why?
|
| Teratoma | 1 | 2021 | 236 | 0.170 |
Why?
|
| Fetal Diseases | 2 | 2019 | 388 | 0.160 |
Why?
|
| Perinatal Care | 1 | 2019 | 63 | 0.160 |
Why?
|
| Cells, Cultured | 4 | 2014 | 5637 | 0.160 |
Why?
|
| Myocytes, Cardiac | 1 | 2003 | 764 | 0.160 |
Why?
|
| Lymphatic Vessels | 1 | 2019 | 143 | 0.150 |
Why?
|
| Placenta Diseases | 1 | 2018 | 56 | 0.150 |
Why?
|
| Video Recording | 1 | 2019 | 267 | 0.150 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2003 | 1678 | 0.140 |
Why?
|
| Infant, Premature, Diseases | 1 | 2019 | 245 | 0.140 |
Why?
|
| Myocardium | 1 | 2003 | 1313 | 0.140 |
Why?
|
| Neck | 1 | 2019 | 383 | 0.140 |
Why?
|
| Health Personnel | 1 | 2021 | 625 | 0.140 |
Why?
|
| Guideline Adherence | 1 | 2020 | 636 | 0.130 |
Why?
|
| Mice, Transgenic | 2 | 2014 | 4143 | 0.130 |
Why?
|
| Immunoglobulin G | 2 | 2019 | 1021 | 0.130 |
Why?
|
| Serum Amyloid P-Component | 1 | 2014 | 32 | 0.130 |
Why?
|
| Cesarean Section | 1 | 2018 | 367 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 3 | 2019 | 6942 | 0.130 |
Why?
|
| Prenatal Diagnosis | 1 | 2019 | 590 | 0.130 |
Why?
|
| Hysterectomy | 1 | 2018 | 611 | 0.120 |
Why?
|
| Developmental Disabilities | 1 | 2019 | 674 | 0.120 |
Why?
|
| Humans | 14 | 2023 | 261506 | 0.120 |
Why?
|
| Mice, Knockout | 2 | 2014 | 5710 | 0.110 |
Why?
|
| Sheep | 2 | 2003 | 258 | 0.110 |
Why?
|
| Dietary Fats | 1 | 2014 | 339 | 0.110 |
Why?
|
| Physician-Patient Relations | 1 | 2019 | 792 | 0.110 |
Why?
|
| Time Factors | 2 | 2020 | 12926 | 0.110 |
Why?
|
| Clinical Competence | 1 | 2020 | 1270 | 0.110 |
Why?
|
| Inositol Polyphosphate 5-Phosphatases | 1 | 2011 | 11 | 0.100 |
Why?
|
| Antigen-Antibody Complex | 1 | 2011 | 115 | 0.100 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 915 | 0.100 |
Why?
|
| Female | 11 | 2023 | 141928 | 0.100 |
Why?
|
| Decision Making | 1 | 2019 | 1287 | 0.100 |
Why?
|
| Nitric Oxide | 1 | 2014 | 644 | 0.090 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2011 | 243 | 0.090 |
Why?
|
| Diabetes Mellitus | 1 | 2019 | 1054 | 0.090 |
Why?
|
| Rabbits | 1 | 2011 | 957 | 0.090 |
Why?
|
| Disease Models, Animal | 2 | 2014 | 7222 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 2403 | 0.090 |
Why?
|
| Cattle | 1 | 2011 | 783 | 0.090 |
Why?
|
| DNA Methylation | 1 | 2019 | 2669 | 0.080 |
Why?
|
| Blood Pressure | 1 | 2014 | 1467 | 0.080 |
Why?
|
| Enzyme Activation | 1 | 2011 | 1764 | 0.080 |
Why?
|
| Animals | 7 | 2019 | 59536 | 0.080 |
Why?
|
| Transfection | 1 | 2011 | 2944 | 0.070 |
Why?
|
| Male | 6 | 2021 | 123000 | 0.070 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 5687 | 0.060 |
Why?
|
| Inflammation | 1 | 2014 | 2522 | 0.060 |
Why?
|
| Hematocrit | 1 | 2003 | 142 | 0.060 |
Why?
|
| Phosphorylation | 1 | 2011 | 4804 | 0.060 |
Why?
|
| Bromodeoxyuridine | 1 | 2003 | 139 | 0.060 |
Why?
|
| Pterins | 1 | 2002 | 10 | 0.060 |
Why?
|
| Aromatic-L-Amino-Acid Decarboxylases | 1 | 2002 | 17 | 0.060 |
Why?
|
| Adult | 5 | 2021 | 77950 | 0.060 |
Why?
|
| Mice | 3 | 2014 | 34495 | 0.050 |
Why?
|
| Hypertrophy | 1 | 2003 | 162 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2003 | 585 | 0.050 |
Why?
|
| Cardiomegaly | 1 | 2003 | 195 | 0.050 |
Why?
|
| Pregnancy, Twin | 1 | 2023 | 118 | 0.050 |
Why?
|
| Carbon Dioxide | 1 | 2003 | 313 | 0.050 |
Why?
|
| Neurotransmitter Agents | 1 | 2002 | 159 | 0.050 |
Why?
|
| Cardiotocography | 1 | 2021 | 16 | 0.050 |
Why?
|
| Blood Gas Analysis | 1 | 2021 | 100 | 0.050 |
Why?
|
| Cardiovascular Diseases | 1 | 2015 | 2195 | 0.050 |
Why?
|
| Hyperplasia | 1 | 2003 | 557 | 0.050 |
Why?
|
| Acidosis | 1 | 2021 | 116 | 0.050 |
Why?
|
| Cell Culture Techniques | 1 | 2003 | 598 | 0.050 |
Why?
|
| Fetus | 1 | 2003 | 601 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 1 | 2003 | 848 | 0.040 |
Why?
|
| Infant Care | 1 | 2019 | 48 | 0.040 |
Why?
|
| Aftercare | 1 | 2021 | 259 | 0.040 |
Why?
|
| Cell Division | 1 | 2003 | 2489 | 0.040 |
Why?
|
| Oxygen | 1 | 2003 | 754 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2011 | 7226 | 0.040 |
Why?
|
| Parturition | 1 | 2019 | 65 | 0.040 |
Why?
|
| Infant Mortality | 1 | 2019 | 186 | 0.040 |
Why?
|
| Heart Ventricles | 1 | 2003 | 846 | 0.040 |
Why?
|
| Pregnancy Outcome | 1 | 2021 | 643 | 0.040 |
Why?
|
| Quantitative Trait Loci | 1 | 2019 | 374 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2015 | 11965 | 0.040 |
Why?
|
| Retrospective Studies | 4 | 2021 | 37905 | 0.040 |
Why?
|
| Diabetes Complications | 1 | 2019 | 305 | 0.040 |
Why?
|
| CpG Islands | 1 | 2019 | 633 | 0.040 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2021 | 830 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2019 | 558 | 0.030 |
Why?
|
| Aging | 1 | 2002 | 1582 | 0.030 |
Why?
|
| Infant | 2 | 2019 | 13310 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2021 | 4971 | 0.030 |
Why?
|
| Alleles | 1 | 2019 | 2437 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 2015 | 419 | 0.030 |
Why?
|
| Ligands | 1 | 2015 | 995 | 0.030 |
Why?
|
| Neurons | 1 | 2002 | 2287 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2019 | 2265 | 0.020 |
Why?
|
| Logistic Models | 1 | 2018 | 3441 | 0.020 |
Why?
|
| Adolescent | 2 | 2021 | 31252 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2021 | 9244 | 0.020 |
Why?
|
| Biomarkers | 1 | 2019 | 5047 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 4549 | 0.020 |
Why?
|
| Head and Neck Neoplasms | 1 | 2021 | 3976 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2021 | 16273 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2021 | 7702 | 0.020 |
Why?
|
| Sweat Glands | 1 | 2002 | 2 | 0.010 |
Why?
|
| Sympathetic Fibers, Postganglionic | 1 | 2002 | 6 | 0.010 |
Why?
|
| Ciliary Neurotrophic Factor | 1 | 2002 | 10 | 0.010 |
Why?
|
| Pteridines | 1 | 2002 | 34 | 0.010 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2002 | 81 | 0.010 |
Why?
|
| Tissue Extracts | 1 | 2002 | 48 | 0.010 |
Why?
|
| Catecholamines | 1 | 2002 | 101 | 0.010 |
Why?
|
| Acetylcholine | 1 | 2002 | 96 | 0.010 |
Why?
|
| Foot | 1 | 2002 | 104 | 0.010 |
Why?
|
| Norepinephrine | 1 | 2002 | 272 | 0.010 |
Why?
|
| Dopamine | 1 | 2002 | 312 | 0.010 |
Why?
|
| Risk Factors | 1 | 2018 | 17523 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 21445 | 0.010 |
Why?
|
| Child | 1 | 2021 | 29154 | 0.010 |
Why?
|
| Skin | 1 | 2002 | 1259 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2018 | 32848 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2002 | 3536 | 0.010 |
Why?
|
| Phenotype | 1 | 2002 | 6295 | 0.010 |
Why?
|